|
Study of Human Botulism Immunoglobulin in Infants With Botulism Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Study of Human Botulism Immunoglobulin in Infants With Botulism conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of Human Botulism Immunoglobulin in Infants With Botulism Clinical research trials and Study of Human Botulism Immunoglobulin in Infants With Botulism medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Study of Human Botulism Immunoglobulin in Infants With Botulism. Study of Human Botulism Immunoglobulin in Infants With Botulism Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Study of Human Botulism Immunoglobulin in Infants With Botulism clinical trial. Participants frequently obtain the most expert healthcare available for their Study of Human Botulism Immunoglobulin in Infants With Botulism condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Human Botulism Immunoglobulin in Infants With Botulism  Study of Human Botulism Immunoglobulin in Infants With Botulism
Study of Human Botulism Immunoglobulin in Infants With Botulism
For Condition: Infant Botulism,Botulism
Status: Recruiting
Sponsor(s): FDA Office of Orphan Products Development , California Department of Health Services
Synopsis: OBJECTIVES: I. Determine the safety of human botulism immune globulin (BIG) in patients with infant botulism by monitoring side effects (e.g., rash, fever, hypotension, and anaphylaxis). II. Assess the efficacy of BIG in these patients by monitoring disease severity, incidence of complications (respiratory arrest, aspiration, pneumonia, etc.), and length of hospital stay.
Details: PROTOCOL OUTLINE: This is an open label, multicenter study. Patients should begin therapy within 72 hours of hospital admission, but may receive human botulism immunoglobulin (BIG) in certain circumstances after 72 hours. Patients receive (BIG) IV. Patients are monitored for side effects, disease severity, complications, and length of hospital stay. Patients are followed at 2 weeks after treatment, then every 4 weeks for 6 months.
Eligibility:
Study Type: Interventional, Treatment, Open Label
Minimum Age/Maximum Age: /1 Year
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- - Clinical diagnosis of infant botulism in previously healthy infant - Bulbar palsies - Constipated Lethargy - Diminished head control - Poor feeding - Generalized weakness and hypotonia - Weak cry - Afebrile (unless secondary infection present) - Subacute to acute onset - Normal electrolytes - Any patient eligible provided no treatment available for life-threatening condition
Total Enrollment: 120
Location and Contact Information:
Overall Study Official:
StephenArnon, Study Chair, California Department of Health Services
California Department of Health Services *Recruiting*
Berkeley, California, 94704-1011
United States
Recruiting Stephen Arnon 510-540-2646
Additional Information:
Study ID Numbers: 199/13253; CDHS-FDU000476
Study Start Date: January 1998
Record last reviewed: March 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004401
Other Botulism Studies:
1. Study of Human Botulism Immunoglobulin in Infants With Botulism
Related Studies:
Other Botulism Clinical Trials
Other California Clinical Trials
Other Berkeley Clinical Trials
Study of Human Botulism Immunoglobulin in Infants With Botulism
|
|
|
|
|
|
|
|
